$8.92
0.688.25%
Last update: Nov 4, 7:51 PM
Capricor Therapeutics Inc
CAPRNASDAQ
The average analyst price target for Capricor Therapeutics is $30.86, 243.3% above the current price. Of 9 analysts, 7 rate it Buy and 2 Hold. Targets range from $13 to $54. The latest change came on Sep 14, 2026, when B. Riley Securities upgraded Capricor Therapeutics from Neutral to Buy and moved its price target from $5 to $21.
Price Target Range — 11 Quarters
Analyst Consensus — 9 Analysts
Rating Trend — Last 9 Months
